Buy or sell Genomind stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Genomind Stock

Genomind is a personalized medicine company specializing in neuropsychiatry.

About Genomind Stock

Genomind is a personalized medicine company specializing in neuropsychiatry. It was founded by a psychiatrist, Dr. Ronald Dozoretz, and a neurologist, Dr. Jay Lombard, who share a common goal of wanting the best possible care for patients who suffer from psychiatric illness. It was founded in 2009 and headquartered in Chalfont, Pennsylvania.

Funding History

April 2014$20.9M
April 2016$17.9M
July 2016$3.0M
February 2017$11.0M
July 2018$500K
September 2020$20.6M

Management

Founder

Ronald I. Dozoretz

Director of Behavioral Science

Francis Brennan

Advisor

Stephen Stahl

Advisor

Scott Aaronson

Advisor

Anil Malhotra

Advisor

Allan Levey

Advisor

Rudolph Tanzi

CEO

Cynthia Kilroy

Chairman of the Board of Directors

Ronald I. Dozoretz

Chief Medical Officer

David Krause

Advisor

Murali Doraiswamy

Advisor

Roy Perlis

Chief Information Officer

Jon Levine

Chief Scientific Officer

David Robbins

US Sales Leader

Laura Miles

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo